Hemant Joshi

Hemant Joshi

Auto-generated profile, based on publicly available information

Hemant Joshi

Department of Gynecology, University Hospital Würzburg, Würzburg, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MHMarkus Haake
Markus Haake
BHBeatrice Haack
Beatrice Haack
TSTina Schäfer
Tina Schäfer
PHPatrick N. Harter
Patrick N. Harter
GMGreta Mattavelli
Greta Mattavelli
Jörg WischhusenJörg Wischhusen
Jörg Wischhusen
Immune checkpoint blockade therapy is beneficial and even curative for some cancer patients. However, the majority don’t respond to immune therapy. Across different tumor types, pre-existing T cell infiltrates predict response to checkpoint-based immunotherapy. Based on in vitro pharmacological studies, mouse models and analyses of human melanoma patients, we show that the cytokine GDF-15 impairs LFA-1/β2-integrin-mediated adhesion of T cells to activated endothelial cells, which is a pre-requisite of T cell extravasation. In melanoma patients, GDF-15 serum levels strongly correlate with failure of PD-1-based immune checkpoint blockade therapy. Neutralization of GDF-15 improves both T cell trafficking and therapy efficiency in murine tumor models. Thus GDF-15, beside its known role in cancer-related anorexia and cachexia, emerges as a regulator of T cell extravasation into the tumor microenvironment, which provides an even stronger rationale for therapeutic anti-GDF-15 antibody development.

15 March 2022 in Cell Reports
Verified
Journal Article
Open access
HJHemant Joshi
Hemant Joshi
AAAlison Almgren-Bell
Alison Almgren-Bell
EAEdgar P. Anaya
Edgar P. Anaya
ETElizabeth M. Todd
Elizabeth M. Todd
SDSteven J. Van Dyken
Steven J. Van Dyken
SMSharon C Morley
Sharon C Morley
Macrophage adhesion and stretching have been shown to induce interleukin (IL)-1β production, but the mechanism of this mechanotransduction remains unclear. Here we specify the molecular link between mechanical tension on tissue-resident macrophages and activation of the NLRP3 inflammasome, which governs IL-1β production. NLRP3 activation enhances antimicrobial defense, but excessive NLRP3 activity causes inflammatory tissue damage in conditions such as pulmonary fibrosis and acute respiratory distress syndrome. We find that the actin-bundling protein L-plastin (LPL) significantly enhances NLRP3 assembly. Specifically, LPL enables apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) oligomerization during NLRP3 assembly by stabilizing ASC interactions with the kinase Pyk2, a component of cell-surface adhesive structures called podosomes. Upon treatment with exogenous NLRP3 activators, lung-resident alveolar macrophages (AMs) lacking LPL exhibit reduced caspase-1 activity, IL-1β cleavage, and gasdermin-D processing. LPL−/− mice display resistance to bleomycin-induced lung injury and fibrosis. These findings identify the LPL-Pyk2-ASC pathway as a target for modulation in NLRP3-mediated inflammatory conditions.

1 June 2021 in Molecular Immunology
Verified
Journal Article
Closed access
HJHemant Joshi
Hemant Joshi
BLBenjamin Lunz
Benjamin Lunz
APAndrea Peters
Andrea Peters
MZMichael Zölch
Michael Zölch
IBIngolf Berberich
Ingolf Berberich
FBFriederike Berberich-Siebelt
Friederike Berberich-Siebelt